TigerOak Management L.L.C. Invests $1.25 Million in Danaher Co. (NYSE:DHR)

TigerOak Management L.L.C. purchased a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 5,446 shares of the conglomerate's stock, valued at approximately $1,250,000.

Several other hedge funds also recently bought and sold shares of the company. FMR LLC boosted its holdings in Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock valued at $6,566,116,000 after acquiring an additional 3,217,631 shares during the period. Van ECK Associates Corp lifted its position in Danaher by 6,862.7% in the fourth quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate's stock valued at $213,452,000 after purchasing an additional 916,513 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Danaher by 17.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock worth $996,141,000 after purchasing an additional 535,254 shares during the last quarter. International Assets Investment Management LLC raised its holdings in Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after buying an additional 428,897 shares during the last quarter. Finally, Montrusco Bolton Investments Inc. boosted its position in Danaher by 30.4% during the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock valued at $465,617,000 after buying an additional 397,671 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Trading Up 0.3 %

Shares of DHR traded up $0.70 during mid-day trading on Wednesday, reaching $205.23. 4,572,680 shares of the company's stock traded hands, compared to its average volume of 4,519,168. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock's 50-day moving average is $228.34 and its two-hundred day moving average is $248.10. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The stock has a market cap of $148.24 billion, a P/E ratio of 38.87, a P/E/G ratio of 2.63 and a beta of 0.83.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the firm posted $2.09 EPS. Research analysts forecast that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend was Friday, December 27th. Danaher's dividend payout ratio (DPR) is presently 20.45%.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 10.90% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on DHR. Raymond James reiterated a "market perform" rating on shares of Danaher in a report on Monday, February 3rd. Bank of America raised Danaher from a "neutral" rating to a "buy" rating and set a $290.00 target price for the company in a report on Friday, December 13th. StockNews.com cut Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, December 14th. Wells Fargo & Company dropped their target price on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a report on Thursday, January 30th. Finally, Robert W. Baird dropped their price target on Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.